本页面由Tiger Trade Technology Pte. Ltd.提供服务

Innate Pharma SA

1.52
-0.1050-6.48%
成交量:2.58万
成交额:3.88万
市值:1.70亿
市盈率:-2.59
高:1.52
开:1.48
低:1.48
收:1.62
52周最高:2.71
52周最低:1.17
股本:1.12亿
流通股本:8,844.50万
量比:0.97
换手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):-0.5840
每股收益(LYR):-0.6458
净资产收益率:-271.37%
总资产收益率:-46.60%
市净率:-3.75
市盈率(LYR):-2.35

数据加载中...

2026/06/22

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/12

SEC问询函

Form CORRESP - Correspondence
2023/04/20

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/06

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/12/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/04

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/07/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/24

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]